EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Biomechanical mapping of tumor growth: A novel method to quantify glioma infiltration and mass effect

Carles López-Mateu, Maria Gómez-Mahiques, F Javier Gil-Terrón, Víctor Montosa-I-Micó, Donatas Sederevičius, Kyrre E Emblem, Juan M García-Gómez, Elies Fuster-García

Medical Physics · 2026

DOI: 10.1002/mp.70334 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Physics, 2026. Verfasst von Carles López-Mateu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Data Science Laboratory, Instituto Universitario de Tecnologías de la Información y Comunicaciones, Universitat Politècnica de València, V…. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Brain Neoplasms, Image Processing, Computer-Assisted, Mechanical Phenomena. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MCIN/AEI (Ministerio de Ciencia, Innovación y Universidades / Agencia Estatal de Investigación), Generalitat Valenciana, European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glioblastoma (GBM) growth can alter surrounding brain tissue through location‐dependent physiological changes. Two main growth phenotypes—(I) infiltrative, characterized by diffuse invasion with minimal mass effect, and (II) proliferative, characterized by pronounced tissue compression—are recognized, but their quantitative characterization and prognostic impact remain poorly explored.

Purpose

To develop and validate a novel MRI‐based biomarker, the Dynamic Infiltration Rate (DIR), that quantitatively assesses the balance between tumor volume expansion and peritumoral compression, and to evaluate its prognostic ability for stratifying patients based on overall survival (OS).

Methods

The DIR was defined as the ratio between tumor‐volume enlargement and mass‐effect–induced peritumoral compression. Technical validation was conducted using synthetic datasets with known ground truth spanning realistic infiltrative–proliferative spectra. Clinically, patients were dichotomized into high‐ and low‐infiltration groups using a threshold optimized by maximizing the log‐rank statistic for OS. Prognostic evaluation included multivariate Cox regression adjusted for age, sex, and MGMT methylation status.

Results

The synthetic dataset validation demonstrated high concordance with ground truth (). Clinical evaluation indicated significantly improved OS in the low DIR group (median = 35.2 weeks) compared to the high DIR group (median = 16.0 weeks; ). DIR effectively stratified patients based on survival (log‐rank , HR = 2.49) and remained an independent prognostic factor on multivariate analysis (HR = 1.45, 95% CI 1.07–1.85; ).

Conclusions

The DIR is a novel and robust quantitative MRI biomarker capable of distinguishing between proliferative and infiltrative GBM phenotypes, independently predicting OS. Early phenotype identification could facilitate personalized treatment strategies and individualized follow‐up scheduling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Magnetic Resonance ImagingBrain NeoplasmsImage Processing, Computer-AssistedMechanical PhenomenaGliomaHumansBiomechanical PhenomenaPrognosisTumor BurdenFemaleMaleGlioblastomaNeoplasm InvasivenessMiddle Aged

Stichwörter der Autor:innen

glioblastomainfiltrationmass effect

Autor:innen und Institutionen

  • Biomedical Data Science Laboratory, Instituto Universitario de Tecnologías de la Información y Comunicaciones, Universitat Politècnica de València, Valencia, Spain.
  • Department of Physics and Computational Radiology, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.

Förderung

  • MCIN/AEI (Ministerio de Ciencia, Innovación y Universidades / Agencia Estatal de Investigación)
  • Generalitat Valenciana
  • European Research Council
  • Helse Sør-Øst RHF
  • Research Council of Norway
  • Norwegian Cancer Society
  • Universitat Politècnica de València
  • Norges Forskningsråd

Zitieren

APA

López-Mateu, C., Gómez-Mahiques, M., Gil-Terrón, F. J., Montosa-I-Micó, V., Sederevičius, D., Emblem, K. E., García-Gómez, J. M., & Fuster-García, E. (2026). Biomechanical mapping of tumor growth: A novel method to quantify glioma infiltration and mass effect. Medical Physics. https://doi.org/10.1002/mp.70334

Vancouver

López-Mateu C, Gómez-Mahiques M, Gil-Terrón FJ, Montosa-I-Micó V, Sederevičius D, Emblem KE, et al. Biomechanical mapping of tumor growth: A novel method to quantify glioma infiltration and mass effect. Medical Physics. 2026. doi:10.1002/mp.70334

BibTeX
@article{LpezMateu2026,
  author = {López-Mateu, Carles and Gómez-Mahiques, Maria and Gil-Terrón, F Javier and Montosa-I-Micó, Víctor and Sederevičius, Donatas and Emblem, Kyrre E and García-Gómez, Juan M and Fuster-García, Elies},
  title = {Biomechanical mapping of tumor growth: A novel method to quantify glioma infiltration and mass effect},
  journal = {Medical Physics},
  year = {2026},
  doi = {10.1002/mp.70334}
}
Kostenlos starten →